Studies support dexmedetomidine for ICU ventilation patients

03/22/2012 | MedPage Today (free registration)

Dexmedetomidine, a lighter sedative that does not have respiratory depressive effects, was as effective as midazolam or propofol for long-term sedation in ventilated ICU patients, Bern University researchers reported in two studies in the Journal of the American Medical Association. Data also showed dexmedetomidine may reduce the duration of ventilation and that patients were more easily aroused and better able to communicate with staff compared with those on midazolam.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX